Results 251 to 260 of about 458,686 (310)

Disability-adjusted life years for colorectal cancer in China, 2017-2030: A prevalence-based analysis focusing on the impact of screening coverage and the application of local weights. [PDF]

Chin Med J (Engl)
Wu Y, Li Y, Wang X, Zhou X, Yan X, Wang H, Zhu J, Chen W, Shi J.   +8 more
europepmc   +1 more source

Impact of Evolving Treatment Patterns on Interstitial Lung Disease Progression in Systemic Sclerosis Using the European Scleroderma Trials and Research Database

Arthritis &Rheumatology, EarlyView.
Objective The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasingly available immunosuppressive therapies (ISTs) and antifibrotic treatments. However, their real‐world use remains unclear.
Corrado Campochiaro, Marie‐Elise Truchetet, Madelon Vonk, Giacomo De Luca, Giovanna Cuomo, Lidia P. Ananieva, Eric Hachulla, Vanessa Smith, Ana Maria Gheorghiu, Radim Becvar, Patricia Carreira, Nicolas Hunzelmann, Daniel E. Furst, Vera Ortiz‐Santamaria, Francesco Del Galdo, Marco Matucci‐Cerinic, Anna‐Maria Hoffmann‐Vold, EUSTAR collaborators   +17 more
wiley   +1 more source

Incidence, mortality, and disability-adjusted life years of female breast cancer in China, 2022. [PDF]

Chin Med J (Engl)
Sun K, Zhang B, Lei S, Zheng R, Liang X, Li L, Feng X, Zhang S, Zeng H, Yao Y, Ma P, Wang S, Chen R, Han B, Wei W, He J.   +15 more
europepmc   +1 more source

Age [PDF]

, 2010
Allmark, Peter, Grimsley, M, Hyde, Martin   +2 more
core  

Prescribing of Medication to Prevent Glucocorticoid Harms in Patients With Polymyalgia Rheumatica: A Cross‐Sectional Study and Two Emulated Target Trials in the Clinical Practice Research Datalink Aurum

Arthritis &Rheumatology, EarlyView.
Objective Polymyalgia rheumatica (PMR) is a common indication for long‐term glucocorticoid (GC) treatment. Bone‐protective and gastroprotective medications are recommended for those at high risk of adverse events from GCs, but no trials have evaluated their effectiveness in PMR.
Helen Twohig, David Jenkinson, James Bailey, Samantha Hider, Ian C. Scott, Sara Muller   +5 more
wiley   +1 more source

Prevalence, deaths and disability-adjusted life years due to Alzheimer's disease and other dementias in Middle East and North Africa, 1990-2021. [PDF]

Sci Rep
Amiri F, Safiri S, Shamekh A, Ebrahimi A, Sullman MJM, Kolahi AA.   +5 more
europepmc   +1 more source

Global, regional, and national burden of interstitial lung diseases and pulmonary sarcoidosis from 2000 to 2021: a systematic analysis of incidence, mortality, and disability-adjusted life years. [PDF]

Front Public Health
Zhou M, Zhou Y, Yang X, Zhou K, Zhu X.
europepmc   +1 more source

Global trends in chronic kidney disease mortality and disability-adjusted life years attributable to low physical activity (1990-2021): a growing public health challenge. [PDF]

BMC Nephrol
Zhao Z, Mi J, Jin H, Li S, Bai X.
europepmc   +1 more source

Tuberculosis incidence, deaths and disability-adjusted life years in children and adolescence, 1990-2021: Results from the Global Burden of Disease Study 2021. [PDF]

PLoS One
Li X, Li Y, Guo L, Chen Y, Wang G, Zhang H.   +5 more
europepmc   +1 more source

Trends in mortality, disability-adjusted life years, and years of healthy life lost due to self-harming in Brazilian states from 1990 to 2019. [PDF]

Rev Saude Publica
Fonseca MS, Santos GGD, Souza PC, Azevedo LH, Armond JE, Neves LM.   +5 more
europepmc   +1 more source